DSIP (Delta Sleep-Inducing Peptide) | Research Grade
AUD $80
For laboratory research use only. Not for human use.
Research-grade DSIP — the delta sleep-inducing peptide studied for sleep regulation, stress modulation, and neuroendocrine function in preclinical models. Third-party HPLC tested to ≥98% purity. For laboratory research use only.
Supply Specifications
| Peptide | DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) |
| Format | Lyophilised powder |
| Purity | ≥98% by HPLC |
| Testing | Third-party HPLC + Mass Spec |
| Storage | -20°C lyophilised |
| Use | Laboratory research use only |
| Price | AUD $80 |
Research Summary
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide first isolated from rabbit cerebral venous blood in 1977. It has been studied in preclinical models for its apparent role in sleep regulation, stress modulation, and neuroendocrine function.
Research has examined DSIP's apparent effects on slow-wave (delta) sleep in rodent models and its interaction with the hypothalamic-pituitary-adrenal (HPA) axis. It is not TGA-approved for human use in Australia and is available for laboratory research use only.
Related Research
Disclaimer: All products supplied by PeptideIQ are for laboratory research use only. They are not approved for human use, consumption, or therapeutic application. PeptideIQ complies with all applicable Australian regulations including the Therapeutic Goods Act 1989.